Public pharma is an alternative to our current profit-driven pharmaceutical system. Public pharma uses the public sector to research, develop, manufacture, and distribute drugs.
“Fixing a Broken System: The Path to Public Pharma in New York” is a critical discussion that will illuminate the transformative potential of publicly owned, manufactured, and distributed pharmaceuticals as we confront an industry that has prioritized profits over patients for too long, leaving patients without access to the medications they need to survive.
The discussion was organized by T1International, the NY #insulin4all Chapter, NYU Law’s Science, Health, and Information Clinic, and The Health and Political Economy Project of the New School's Institute on Race, Power, and Political Economy, and hosted by the Engelberg Center on Innovation Law & Policy. Speakers included New York State Assemblymember Jenifer Rajkumar, former New York City Health Commissioner Dave Chokshi, and Yale School of Medicine Professor Kasia Lipska.
